Guanethidine

This classification denotes an antihypertensive agent with the molecular formula C10H22N4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZTI6C33Q2Q, chemically known as 2-(1-n,n-heptamethyleneimino)ethylguanidine but generally known as guanethidine, which bears US NIH Compound Identifier 3518. European Medicines Agency schedules Guanethidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07984MIG. The term GUANETHIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules guanethidine in its Anatomical Therapeutic Chemical (ATC) Classification. GUANETHIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule guanethidine under HS 29339990 and SITC 51577. As of Q4 2014, GUANETHIDINE remains the US FDA Preferred Term for this commodity. Guanethidine bears US NLM identifiers UMLS ID C0018318 and NCI Concept Code C65830. SMILES: C1CCCN(CCC1)CCN=C(N)N.